<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "ondansetron liq ORAL>
<dose><value>8</value>
<value>16</value>
<value>4</value>
</dose><route><value>PO</value>
<value>PO/IV</value>
</route><form><value>liq ORAL</value>
</form><drugname><value>ondansetron liq ORAL</value>
</drugname><strength><value>0.8 mg/mL</value>
</strength><frequency><value>Q8H</value>
<value>BID</value>
<value>ONCE</value>
<value>TID</value>
<value>Q4H</value>
<value>Q6H</value>
</frequency><instruction><value></value>
<value>Administer one hour pre-chemotherapy. Dose may also be administered by IV route.</value>
<value>Administer two hours pre-chemotherapy. Dose may also be administered by IV route.</value>
<value>for 3 days. Start the evening of chemotherapy. Dose may also be administered by IV route.</value>
<value>Dose may also be administered by IV route.</value>
<value>Administer 1 hour pre-operatively.</value>
</instruction><volume><value></value>
</volume><units><value>mg</value>
</units><additionalnotes><value></value>
</additionalnotes><population><value></value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_Formulary?search_details.aspx?id=1654</value>
</backgroundinformation><prninformation><value></value>
<value>YES</value>
</prninformation><ahsformularystatus><value>Formulary with Usage guidelines.</value>
</ahsformularystatus><ahfsname><value>Antiemetics, 5-HT3 Receptor Antagonists</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>